Otsuka Holdings Co., Ltd. (TSE: 4578)
Health Care · Pharmaceuticals · JP
¥12,195.00
-3.21% today · +51.2% 1Y
Otsuka Holdings Co., Ltd. (TSE: 4578) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $40.30B and employs 37,758 people.
Over the last twelve months the share price has gained 51.2%, trading between 7.66K and 12.79K.
Tweenvest scores Otsuka Holdings Co., Ltd. across four factors: quality 78/100, value 26/100, growth 60/100, dividend 61/100. Its strongest factor is quality.
4578 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $40.30B
- Revenue (TTM)
- $16.12B
- P/E
- 15.88
- EPS
- 768.08
- Dividend yield
- 1.64%
- Beta (5Y)
- -0.06
- 52-week high
- ¥12,795.00
- 52-week low
- ¥7,655.00
- Avg volume (3M)
- —
- Shares outstanding
- 525.39M
- Employees
- 37,758
- Next earnings
- —
About Otsuka Holdings Co., Ltd.
Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. It develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, autoimmune space digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment and tools, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement equipment, nutritional products, vehicle headlight testers, synthetic resin molded products, paper products, quasi-drugs, household products, and packaging materials and electronic parts. In addition, it offers IT solutions; adhesive tapes; flaky titanate and compounds; infusion and clinical nutrition products; hydrazine; plant-based food products; reinsurance underwriting services; wine; stable isotopes; food supplements; software and services for management of mental healthcare systems; anticancer drugs; terracess; bio-pesticides; dietetic food products; spring and mineral water; and polyolefin foams. Further, it engages in the warehousing and transport, medical device operational management, shared service, environmental health management, and venture capital and incubation businesses; rental of medical devices and related products; purchase and sale of agricultural products; import and export trading business; tuberculosis research and development activities; rental of space and office businesses; manufacturing and development of xenotransplantation products; and processing and marketing of functional films, as well as planning, design, production, and construction of ceramic boards and arts, ceramic walls, reliefs, terracotta, ceramic OT and portraits, and ceramic sign boards; and operation of travel agency, and Hotel Ridge and California Table. The company was founded in 1921 and is headquartered in Chiyoda, Japan.
- ISIN
- JP3188220002
- Founded
- 1921
- Listed since
- Dec 15, 2010
- Exchange
- The Tokyo Stock Exchange
- Currency
- JPY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,257.75 | +0.19% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.37 | +0.42% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $153.56 | +0.66% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.90 | -1.25% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.48 | -0.76% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.14 | +0.25% |
Figures last refreshed Aug 18, 2026.